The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neonates have largely been neglected. The aim of this review is to expand on what differentiates the needs of preterm and term neonates from those of the older paediatric subsets, in terms of environment of care, ability to measure and administer the dose (from the perspective of the patient and carer, the routes of administration, the device and the product), neonatal biopharmaceutics and regulatory challenges. This review offers insight into those c...
The development of medicines designed for children can be challenging since this distinct patient po...
The study of medications among pediatric patients has increased worldwide since 1997 in response to ...
Improved global access to novel age-appropriate formulations for paediatric subsets, either of new c...
The development of age-Appropriate formulations should focus on dosage forms that can deliver variab...
The development of age-appropriate formulations should focus on dosage forms that can deliver variab...
INTRODUCTION: The field of neonatal, infant and toddler pharmaceutical development is constantly imp...
To attain effective and safe pharmacotherapy in neonates, caregivers have to consider both the clini...
Drug dosing in neonates should be based on integrated knowledge concerning the disease to be treated...
Drug therapy is a powerful tool for improving neonatal outcome. Despite this, neonatologists still r...
Accurate dosing of the right medicine to the right patient is a key element of safe and efficacious ...
Background: Children often need to be administered very small volumes of medicines that are authoris...
There is no other age as challenging as neonatal, due to the immaturity of organs and the unpredict...
Neonatal drug dosing needs to be based on the physiological characteristics of the newborn and pharm...
Abstract Acceptability of medicines in children and caregivers affects safety and effectiveness of m...
Pharmacotherapy is a powerful tool to improve the outcome of neonates. Unfortunately, the potential ...
The development of medicines designed for children can be challenging since this distinct patient po...
The study of medications among pediatric patients has increased worldwide since 1997 in response to ...
Improved global access to novel age-appropriate formulations for paediatric subsets, either of new c...
The development of age-Appropriate formulations should focus on dosage forms that can deliver variab...
The development of age-appropriate formulations should focus on dosage forms that can deliver variab...
INTRODUCTION: The field of neonatal, infant and toddler pharmaceutical development is constantly imp...
To attain effective and safe pharmacotherapy in neonates, caregivers have to consider both the clini...
Drug dosing in neonates should be based on integrated knowledge concerning the disease to be treated...
Drug therapy is a powerful tool for improving neonatal outcome. Despite this, neonatologists still r...
Accurate dosing of the right medicine to the right patient is a key element of safe and efficacious ...
Background: Children often need to be administered very small volumes of medicines that are authoris...
There is no other age as challenging as neonatal, due to the immaturity of organs and the unpredict...
Neonatal drug dosing needs to be based on the physiological characteristics of the newborn and pharm...
Abstract Acceptability of medicines in children and caregivers affects safety and effectiveness of m...
Pharmacotherapy is a powerful tool to improve the outcome of neonates. Unfortunately, the potential ...
The development of medicines designed for children can be challenging since this distinct patient po...
The study of medications among pediatric patients has increased worldwide since 1997 in response to ...
Improved global access to novel age-appropriate formulations for paediatric subsets, either of new c...